The dawn of prospective pharmacogenetic testing in type 2 diabetes Jose C. Florez Clinical Trials Report 21 March 2009 Pages: 95 - 97
Antigen-based therapy for treating childhood type 1 diabetes Anette-G. ZieglerHeike BoerschmannMarkus Walter Clinical Trials Report 21 March 2009 Pages: 98 - 99
Control of inflammation with alpha1-antitrypsin: A potential treatment for islet transplantation and new-onset type 1 diabetes Gordon C. WeirMaria Koulamnda Invited Commentary 21 March 2009 Pages: 100 - 102
Novel antigens in type 1 diabetes: The importance of ZnT8 Janet M. WenzlauLisa M. FrischHoward W. Davidson OriginalPaper 21 March 2009 Pages: 105 - 112
Differentiation, expansion, and homeostasis of autoreactive T cells in type 1 diabetes mellitus Paolo MontiAnne-Kristin HeningerEzio Bonifacio OriginalPaper 21 March 2009 Pages: 113 - 118
The contribution of hematopoietic stem cells to beta-cell replacement Valeria SordiLorenzo Piemonti OriginalPaper 21 March 2009 Pages: 119 - 124
Microchimerism in type 1 diabetes Berendine vanZylKathleen M. Gillespie OriginalPaper 21 March 2009 Pages: 125 - 129
Disturbed eating behaviors and eating disorders in type 1 diabetes: Clinical significance and treatment recommendations Ann E. Goebel-Fabbri OriginalPaper 21 March 2009 Pages: 133 - 139
Cognitive and psychosocial aspects of caring for elderly patients with diabetes Isao IwataMedha N. Munshi OriginalPaper 21 March 2009 Pages: 140 - 146
Psychosocial issues in youth with type 2 diabetes mellitus Barbara J. AndersonSiripoom V. McKay OriginalPaper 21 March 2009 Pages: 147 - 153
Genome-wide association studies in type 1 diabetes Struan F.A. GrantHakon Hakonarson OriginalPaper 21 March 2009 Pages: 157 - 163
Genome-wide association studies in type 2 diabetes Mark I. McCarthyEleftheria Zeggini OriginalPaper 21 March 2009 Pages: 164 - 171
